Core Laboratories Sees Q2 GAAP EPS $0.17-$0.21 vs $0.24 Est; Sees Sales $128.000M-$134.000M vs $136.01M Est
Benzinga Newsdesk 1 year ago
NewsGuidance
Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.17-$0.21 vs $0.24 analyst estimate. sees sales of $128.000 million-$134.000 million vs $136.01 million analyst estimate.
Core Laboratories (NYSE:CLB) is looking for Q2 GAAP EPS of $0.17-$0.21 vs $0.24 analyst estimate. sees sales of $128.000 million-$134.000 million vs $136.01 million analyst estimate.